Clariant Ag · SIX:CLN
Clariant — H1 2019 Earnings Presentation
26 slides from Clariant's earnings presentation, Jul 25, 2019
Slide 1: First Half Year Results 2019
First Half Year Results 2019 25 JULY 2019
Slide 2: Disclaimer
2 First Half Year Results 2019 25 July 2019 Disclaimer This presentation contains certain statements that are neither reported financial results nor other historical information. This presentation also includes forward-looking statements. Because these forward-looking statements are subject to risks
Slide 3: Clariant's New Reporting Structure
3 First Half Year Results 2019 25 July 2019 Clariant’s New Reporting Structure Decision Towards a More Focused, High Value Specialty Portfolio − Decision to dispose of entire (standard and high value) Masterbatches and Pigments − Reclassification of these activities to discontinued operations − Clar
Slide 4: First Half Year 2019 – Summary
4 First Half Year Results 2019 25 July 2019 First Half Year 2019 – Summary H1 2019 vs. H1 2018, figures from continuing operations SALES 2 229 + 4 % in CHF m in LC* y-o-y EBITDA after exceptional items 333** - 2 % 14.9 % EBITDA after exceptional items 102*** n.m. n.m. in CHF m in CHF y-o-y margin in
Slide 5: Sales Development & Mix
5 First Half Year Results 2019 25 July 2019 Sales Development & Mix All figures continuing operations − H1 2019 sales rose organically by 4 % in local H1 2019 SALES in CHF m currency, supported by higher volumes and +3% +0% -4% pricing − Good sales expansion driven by Catalysis and Natural Resources
Slide 6: Sales Distribution by Region
6 First Half Year Results 2019 25 July 2019 Sales Distribution by Region Emerging markets All figures continuing operations Mature markets − In H1 2019, sales expansion was most H1 2019 SALES CHF 2 229 m pronounced in Latin America and Middle East & in CHF m Africa ASIA-PACIFIC EUROPE 563 / + 5 %* 7
Slide 7: Care Chemicals
7 First Half Year Results 2019 25 July 2019 Care Chemicals All figures continuing operations H1 2019 H1 2018 % CHF % LC* − H1 2019 sales remained unchanged in LC* Sales in CHF m 850 884 -4 % 0% − Consumer Care sales climbed with positive contributions from EBITDA a.e.i.** in CHF m 150 161 -7 % all t
Slide 8: Catalysis
8 First Half Year Results 2019 25 July 2019 Catalysis All figures continuing operations H1 2019 H1 2018 % CHF % LC* − Robust H1 2019 organic sales expansion of 8 % in LC* due to Sales in CHF m 432 404 7% 8% very strong Syngas demand EBITDA a.e.i.** in CHF m 84 87 -3 % − Sales growth benefited from g
Slide 9: Natural Resources (including Additives)
9 First Half Year Results 2019 25 July 2019 Natural Resources (including Additives) All figures continuing operations H1 2019 H1 2018 % CHF % LC* − H1 2019 sales rose 6 % in LC* Sales in CHF m 947 936 1% 6% − Oil & Mining Services (OMS) reported mid-teen sales growth in EBITDA a.e.i.** in CHF m 148
Slide 10: First Half Year 2019 – EBITDA a.e.i. Development
10 First Half Year Results 2019 25 July 2019 First Half Year 2019 – EBITDA a.e.i.* Development All figures continuing operations H1 EBITDA a.e.i.* / margin in CHF m / in % of sales − H1 2019 EBITDA a.e.i.* was negatively 400 15.3 % 14.9 % 16.1 % impacted by the one-off provision of CHF 231 m and the
Slide 11: Second Quarter 2019 – EBITDA a.e.i. Development
11 First Half Year Results 2019 25 July 2019 Second Quarter 2019 – EBITDA a.e.i.* Development All figures continuing operations Q2 EBITDA a.e.i.* / margin in CHF m / in % of sales − Due to the one-off provision, the Q2 2019 EBITDA a.e.i.* decreased significantly to 14.9 % 14.0 % 15.0 % 14.0 % 13.0 %
Slide 12: First Half Year 2019 – Net Result
12 First Half Year Results 2019 25 July 2019 First Half Year 2019 – Net Result All figures including discontinued operations − Due to the one-off provision, the net result NET RESULT* was CHF -101 m 250 in CHF m 200 150 − The net result excluding the provision was 100 211 CHF 130 m, which in turn wa
Slide 13: Outlook
a CLARIANT Outlook what is precious to you?
Slide 14: A More Focused, High Value Specialty Portfolio
14 First Half Year Results 2019 25 July 2019 A More Focused, High Value Specialty Portfolio CARE CHEMICALS CATALYSIS NATURAL RESOURCES* BA Care Chemicals comprises the BU BA Catalysis comprises the BU Catalysts and BA Natural Resources, comprises the BUs Oil & Industrial & Consumer Specialties (ICS)
Slide 15: Outlook 2021: Decision Towards a More Focused Portfolio
15 First Half Year Results 2019 25 July 2019 Outlook 2021: Decision Towards a More Focused Portfolio to Achieve Above-Market Growth, Higher Profitability and Stronger Cash Generation − Clariant is a focused and innovative specialty chemical company. We aim to provide more than just customer-oriented
Slide 16: Back-up Slides
a CLARIANT Back-up Slides what is precious to you?
Slide 17: Business Area Overview FY 2018: Sales and EBITDA
17 First Half Year Results 2019 25 July 2019 Business Area Overview FY 2018: Sales and EBITDA Sales to 3rd parties EBITDA a.e.i. EBITDA margin composition distribution by Business Area distribution1 and overview by Business Area (share by BU in portfolio based on sales) CLARIANT EBITDA a.e.i. CHF m
Slide 18: Discontinued Operations (Masterbatches and Pigments)
18 First Half Year Results 2019 25 July 2019 Discontinued Operations (Masterbatches and Pigments) H1 2019 H1 2018 % CHF % LC* − In H1 2019, sales decreased by 2 % in LC* and 5 % in Swiss Sales in CHF m 1 109 1 165 -5 % -2 % francs due to the challenging economic environment − Masterbatches and Pigme
Slide 19: First Half Year 2019 – Sales and EBITDA by Business Area
19 First Half Year Results 2019 25 July 2019 First Half Year 2019 – Sales and EBITDA by Business Area Sales to 3rd parties EBITDA First Half Year after exceptionals in CHF m 2019 2018 % LC* 2019 2018 % CHF Care Chemicals 850 884 0% 150 161 -7 % margin 17.6 % 18.2 % Catalysis 432 404 8% 84 87 -3 % ma
Slide 20: Quarterly and FY 2018 – Sales and EBITDA by Business Area
20 First Half Year Results 2019 25 July 2019 Quarterly and FY 2018 – Sales and EBITDA by Business Area EBITDA Sales to 3rd parties after exceptionals in CHF m Q1 2018 Q2 2018 Q3 2018 Q4 2018 FY 2018 Q1 2018 Q2 2018 Q3 2018 Q4 2018 FY 2018 Care Chemicals 484 400 385 396 1 665 88 73 83 70 314 margin 1
Slide 21: First Half Year 2019 – Key Financials
21 First Half Year Results 2019 25 July 2019 First Half Year 2019 – Key Financials 2019 2018 Continuing operations CHF m % of sales CHF m % of sales Sales 2 229 100.0 % 2 224 100.0 % Local currency growth 4% Organic growth* 4% Acquisitions / divestures 0% Currencies -4 % Gross profit 696 31.2 % 698
Slide 22: First Half Year 2019 – Consolidated Statements of Cash Flows
22 First Half Year Results 2019 25 July 2019 First Half Year 2019 – Consolidated Statements of Cash Flows All figures including discontinued operations CHF m 2019 2018 Net result -101 211 Depreciation, amortization and impairment 184 163 Payments for restructuring -16 -25 Other 115 155 Cash flow bef
Slide 23: Debt Maturity Profile as of June 2019
23 First Half Year Results 2019 25 July 2019 Debt Maturity Profile as of 30 June 2019 LIQUIDITY FINANCIAL DEBT MATURITIES in CHF m in CHF m 700 Derivatives 600 3* Short-term loans, lease & other liabilities 500 Certificate of indebtedness CHF bond 400 41 3 Cash and short-term deposits 300 2 79 579 1
Slide 24: Calendar of Upcoming Corporate Events
24 First Half Year Results 2019 25 July 2019 Calendar of Upcoming Corporate Events 30 October 2019 Nine Months 2019 Reporting 13 February 2020 Full Year 2019 Reporting 30 March 2020 Annual General Meeting
Slide 25: IR Contacts
25 First Half Year Results 2019 25 July 2019 IR Contacts Anja Pomrehn Phone: +41 61 469 63 73 Head of Investor Relations Email: investor-relations@clariant.com Maria Ivek Senior Investor Relations Officer
Slide 26: Our iPad App
26 First Half Year Results 2019 25 July 2019 Our iPad App Download it here: iPad App: www.clariant.com/IRapp